Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT00794950
Title Bacillus Calmette-Guerin Followed by Sunitinib for the Treatment of High Risk Non-muscle Invasive Lower Urinary Tract Urothelial Carcinoma
Acronym Sutent
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Michigan
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Mark P. Schoenberg, MD Baltimore Maryland 21287-2101 United States Details
Alon Weizer, MD Ann Arbor Michigan 48109 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field